Oncology and Hematology
Episodes 1-16 of 73
- CME/CE
Optimal Sequencing of ADCs in Endocrine Refractory HR+/HER2- Metastatic Breast Cancer
0.50 creditsJavier Cortes, MD, PhD
Komal Jhaveri, MD, FACP
Jeffrey V. Matous, MD
Donna Catamero, NP
Ajai Chari, MD
Egbert Smit, MD
Nadia Harbeck, MD, PhD
Egbert Smit, MD
Susana Campos, MD, MPH
- MinuteCE®
ADCs on the Horizon for Breast Cancer: Managing Treatment-Emergent Toxicities
1.00 program creditNadia Harbeck, MD, PhD
Egbert Smit, MD
Susana Campos, MD, MPH
Nadia Harbeck, MD, PhD
Susana Campos, MD, MPH
- MinuteCE®
Emerging ADC Therapies for NSCLC: Anticipating AEs Reported in Clinical Trials
1.00 program creditEgbert Smit, MD
Nadia Harbeck, MD, PhD
Egbert Smit, MD
Caitlin Costello, MD
Sagar Lonial, MD, FACP
- Prev
- Next